The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP.

Blood 2007 Mar 14;109(5):1857-61. Epub 2006 Nov 14.

Division of Medical Oncology, British Columbia Cancer Agency and the University of British Columbia, Vancouver, Canada.

Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous entity, with patients exhibiting a wide range of outcomes. The addition of rituximab to CHOP chemotherapy (R-CHOP)has led to a marked improvement in survival and has called into question the significance of previously recognized prognostic markers. Since randomized controlled trials of R-CHOP in DLBCL have included select subgroups of patients, the utility of the International Prognostic Index (IPI) has not been reassessed. We performed a retrospective analysis of patients with DLBCL treated with R-CHOP in the province of British Columbia to assess the value of the IPI in the era of immunochemotherapy. The IPI remains predictive, but it identifies only 2 risk groups. Redistribution of the IPI factors into a revised IPI (R-IPI) provides a more clinically useful prediction of outcome. The R-IPI identifies 3 distinct prognostic groups with a very good (4-year progression-free survival [PFS] 94%, overall survival [OS] 94%), good (4-year PFS 80%, OS 79%), and poor (4-year PFS 53%, OS 55%) outcome, respectively (P < .001). The IPI (or R-IPI) no longer identifies a risk group with less than a 50% chance of survival. In the era of R-CHOP treatment, the R-IPI is a clinically useful prognostic index that may help guide treatment planning and interpretation of clinical trials.

Download full-text PDF

Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2006-08-03
Publisher Site
http://dx.doi.org/10.1182/blood-2006-08-038257DOI Listing
March 2007
12 Reads

Publication Analysis

Top Keywords

identifies risk
8
treated r-chop
8
b-cell lymphoma
8
4-year pfs
8
ipi r-ipi
8
good 4-year
8
r-ipi clinically
8
diffuse large
8
large b-cell
8
international prognostic
8
ipi
7
prognostic
5
r-ipi
5
redistribution ipi
4
ipi factors
4
groups redistribution
4
subgroups patients
4
risk groups
4
factors revised
4
predictive identifies
4

Altmetric Statistics

References

(Supplied by CrossRef)

Similar Publications